Search - tctmd.com

Displaying 561 - 580 of 3616

Sort: Relevancy | Date

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Industry News

New Research Shows Abbott's High Sensitive Troponin Test First To Measure Impact Of Mental Stress On The Heart

April 04, 2016

News Conference News ACC 2016

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

Yael L. Maxwell

April 04, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Conference News ACC 2016

Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money

Caitlin E. Cox

April 04, 2016

News Industry News

CardioFocus' HeartLight® System Granted FDA Approval for Treatment of Atrial Fibrillation (AF)

April 04, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Industry News

St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations

April 04, 2016

News Conference News ACC 2016

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Todd Neale

April 04, 2016

News Conference News ACC 2016

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

L.A. McKeown

April 03, 2016

News Conference News ACC 2016

Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience

Todd Neale

April 03, 2016

News Conference News ACC 2016

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Shelley Wood

April 03, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

Caitlin E. Cox

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Conference News ACC 2016

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

Michael O'Riordan

April 02, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Daily News

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

Michael O'Riordan

March 31, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

Advertisement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

New Research Shows Abbott's High Sensitive Troponin Test First To Measure Impact Of Mental Stress On The Heart

Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

Involving Low-Risk Patients in Chest Pain Test Decisions Eases Fears, Saves Money

CardioFocus' HeartLight® System Granted FDA Approval for Treatment of Atrial Fibrillation (AF)

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience

TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough?

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content